CRI BIOTECH Trademark

Trademark Overview

On Thursday, October 3, 2019, a trademark application was filed for CRI BIOTECH with the United States Patent and Trademark Office. The USPTO has given the CRI BIOTECH trademark a serial number of 88640226. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Sunday, April 13, 2025. This trademark is owned by CARDIAC RSK3 INHIBITORS, LLC. The CRI BIOTECH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research in the field of gene therapy for the treatment of heart failure
cri biotech

General Information

Serial Number88640226
Word MarkCRI BIOTECH
Filing DateThursday, October 3, 2019
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateSunday, April 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"BIOTECH"
Pseudo MarkCARDIAC RISKED INHIBITORS BIO TECH; CARDIAC RSK THREE INHIBITORS BIOTECH; CARDIAC RISKE INHIBITORS BIOTECH
Goods and ServicesMedical research in the field of gene therapy for the treatment of heart failure

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 7, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCRI BIOTECH, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLOS ALTOS, CA 94024
Party NameCARDIAC RSK3 INHIBITORS, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLos Altos, CA 94024

Trademark Events

Event DateEvent Description
Monday, October 7, 2019NEW APPLICATION ENTERED
Monday, October 7, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 8, 2020ASSIGNED TO EXAMINER
Sunday, January 19, 2020NON-FINAL ACTION WRITTEN
Sunday, January 19, 2020NON-FINAL ACTION E-MAILED
Sunday, January 19, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 2, 2020SUSPENSION LETTER WRITTEN
Monday, March 2, 2020LETTER OF SUSPENSION E-MAILED
Monday, March 2, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 2, 2020ASSIGNED TO LIE
Friday, November 13, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 13, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 9, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 13, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 30, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, January 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 22, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 7, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 6, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 8, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, April 13, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 14, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, October 15, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

biotech treatment heart failure therapy gene research field medical